$0.89
0.84% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US37185R2085
Symbol
GENE
Sector
Industry

Genetic Technologies Limited Sponsored ADR Stock price

$0.89
+0.16 21.82% 1M
-2.00 69.32% 6M
-1.52 63.13% YTD
-3.12 77.88% 1Y
-16.47 94.90% 3Y
-9.20 91.23% 5Y
-66.12 98.68% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.01 0.84%
ISIN
US37185R2085
Symbol
GENE
Sector
Industry

Key metrics

Market capitalization $7.21m
Enterprise Value $7.11m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.42
P/S ratio (TTM) P/S ratio 1.44
P/B ratio (TTM) P/B ratio 3.34
Revenue growth (TTM) Revenue growth -14.07%
Revenue (TTM) Revenue $5.02m
EBIT (operating result TTM) EBIT $-8.01m
Free Cash Flow (TTM) Free Cash Flow $-6.30m
EPS (TTM) EPS $-1.95
Short interest 0.43%
Show more

Is Genetic Technologies Limited Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Genetic Technologies Limited Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Genetic Technologies Limited Sponsored ADR:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Genetic Technologies Limited Sponsored ADR:

Buy
100%

Financial data from Genetic Technologies Limited Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
5.02 5.02
14% 14%
100%
- Direct Costs 7.93 7.93
3% 3%
158%
-2.91 -2.91
56% 56%
-58%
- Selling and Administrative Expenses 4.02 4.02
14% 14%
80%
- Research and Development Expense 0.74 0.74
14% 14%
15%
-7.66 -7.66
23% 23%
-153%
- Depreciation and Amortization 0.35 0.35
24% 24%
7%
EBIT (Operating Income) EBIT -8.01 -8.01
19% 19%
-160%
Net Profit -7.87 -7.87
1% 1%
-157%

In millions USD.

Don't miss a Thing! We will send you all news about Genetic Technologies Limited Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Genetic Technologies Limited Sponsored ADR Stock News

Neutral
GlobeNewsWire
about one month ago
CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease and the parent company of geneType™, has conducted an operations review and announces that it intends to transition to a capital light operations model – which is anticipated to result in an i...
Neutral
GlobeNewsWire
about 2 months ago
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness, and serious disease, is pleased to announce the appointment of Mark Ziirsen as Chief Financial Officer (CFO) and Company Secretary.
Neutral
GlobeNewsWire
2 months ago
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifying risk and improving the health of populations worldwide.
More Genetic Technologies Limited Sponsored ADR News

Company Profile

Genetic Technologies Ltd. engages in the provision of molecular risk assessment for cancer. It operates through the USA and Australia geographical segments. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Head office Australia
CEO Simon Morriss
Employees 60
Founded 1987
Website www.genetype.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today